FDA Expands Age Range for Use of Bacterial Meningitis Vaccine
FDA Expands Age Range for Use of Bacterial Meningitis Vaccine
The U.S. Food and Drug Administration today expanded the approved age range for Menactra, a bacterial meningitis vaccine, to include children ages 2 to 10 years.